Cannabis Law Report

APRIL 17, 2022

and any donation will help make an impact. Bumpin’ Uglies – Make It Through The Day. Supplementary Information: [link]. Want to join me in making a difference? I’m raising money to benefit Muscular Dystropy Association, Inc., Thanks in advance for your contribution to this cause that means so much to me.

Collective 59

Collective Advocacy Topical Education 59

Cannabis Law Report

APRIL 21, 2022

Since its founding, MAPS has raised over $130 million in donations and grants for psychedelic and marijuana research and education and has earned both the Guidestar Platinum Seal of Transparency and a 4-Star Rating from Charity Navigator.

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

Cannabis Law Report

APRIL 9, 2022

Additionally, you can donate to or invest in research initiatives that are working to improve our understanding of marijuana and its potential medical benefits. As a business, you can also help shape the future of the legal marijuana industry in California.

Business 59

Business Legalization Marijuana Research and Development 59

Leafly

APRIL 28, 2022

Cannabis for Black Lives is a non-profit organization dedicated to supporting Black-led cannabis companies. The post How to join Cannabis for Black Lives and support Black-led cannabis businesses appeared first on Leafly.

Business 85

Business Cannabis 85

The Cannigma

APRIL 7, 2022

Just donate as well. Everything we do, we need donations for. When you’re a member, everything that we do, you are helping us with. Members are so important for us. We have a certain few members-only webinars throughout the year and things like that. Everything, we have to have funding for.

Terpenes 52

Terpenes Wellness and Beauty Cannabis Extraction 52

Cannabis Law Report

APRIL 8, 2022

MAPS continued to publish Bulletin articles about MDMA research , requests for donations , and discontinuing animal studies. MAPS started research into ayahuasca for addiction , and the late Ashawna Hailey provided a donation of $5.5 MAPS Founder Rick Doblin, Ph.D., MAPS also started research into ibogaine for opiate addiction.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52